Advertisement
DVA vs FMS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVA is a StrongBuy and FMS is a StrongBuy.
DVA in upward trend: price rose above 50-day moving average on October 22, 2026
DVA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on DVA as a result. In 62 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for DVA just turned positive on October 05, 2026. Looking at past instances where DVA's MACD turned positive, the stock continued to rise in 24 of 41 cases over the following month. The odds of a continued upward trend are 59%.
The 10-day moving average for DVA crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +6.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where DVA advanced for three days, in 242 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 66 cases where DVA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
DVA broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DVA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. DVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 51 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-15.313) is normal, around the industry mean (204.136). P/E Ratio (14.810) is within average values for comparable stocks, (19.375). Projected Growth (PEG Ratio) (0.436) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.098) among similar stocks. P/S Ratio (0.968) is also within normal values, averaging (2.688).
FMS's RSI Oscillator ascends from oversold territory
The RSI Indicator for FMS moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 23 of the 34 cases the stock moved higher. This puts the odds of a move higher at 68%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on FMS as a result. In 51 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for FMS just turned positive on October 15, 2026. Looking at past instances where FMS's MACD turned positive, the stock continued to rise in 22 of 43 cases over the following month. The odds of a continued upward trend are 51%.
FMS moved above its 50-day moving average on October 23, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in 194 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
FMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for FMS entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.961) is normal, around the industry mean (204.136). P/E Ratio (13.663) is within average values for comparable stocks, (19.375). Projected Growth (PEG Ratio) (0.741) is also within normal values, averaging (2.498). Dividend Yield (0.154) settles around the average of (0.098) among similar stocks. P/S Ratio (0.574) is also within normal values, averaging (2.688).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. FMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
DVA | FMS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 88 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 51 | 100 | |
SMR RATING 1..100 | 7 | 78 | |
PRICE GROWTH RATING 1..100 | 47 | 57 | |
P/E GROWTH RATING 1..100 | 23 | 81 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FMS's Valuation (5) in the Medical Or Nursing Services industry is somewhat better than the same rating for DVA (66). This means that FMS’s stock grew somewhat faster than DVA’s over the last 12 months.
DVA's Profit vs Risk Rating (51) in the Medical Or Nursing Services industry is somewhat better than the same rating for FMS (100). This means that DVA’s stock grew somewhat faster than FMS’s over the last 12 months.
DVA's SMR Rating (7) in the Medical Or Nursing Services industry is significantly better than the same rating for FMS (78). This means that DVA’s stock grew significantly faster than FMS’s over the last 12 months.
DVA's Price Growth Rating (47) in the Medical Or Nursing Services industry is in the same range as FMS (57). This means that DVA’s stock grew similarly to FMS’s over the last 12 months.
DVA's P/E Growth Rating (23) in the Medical Or Nursing Services industry is somewhat better than the same rating for FMS (81). This means that DVA’s stock grew somewhat faster than FMS’s over the last 12 months.
| DVA | FMS | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 68% |
| Stochastic ODDS (%) | 3 days ago 67% | 3 days ago 58% |
| Momentum ODDS (%) | 3 days ago 72% | 3 days ago 66% |
| MACD ODDS (%) | 3 days ago 59% | 3 days ago 51% |
| TrendWeek ODDS (%) | 3 days ago 58% | 3 days ago 61% |
| TrendMonth ODDS (%) | 3 days ago 67% | 3 days ago 57% |
| Advances ODDS (%) | 4 days ago 69% | 3 days ago 61% |
| Declines ODDS (%) | 6 days ago 55% | 6 days ago 64% |
| BollingerBands ODDS (%) | 3 days ago 64% | 3 days ago 67% |
| Aroon ODDS (%) | 3 days ago 55% | 3 days ago 67% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DVA’s FA Score shows that 2 FA rating(s) are green while FMS’s FA Score has 1 green FA rating(s).
- DVA’s FA Score: 2 green, 3 red.
- FMS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DVA’s TA Score shows that 5 TA indicator(s) are bullish while FMS’s TA Score has 6 bullish TA indicator(s).
- DVA’s TA Score: 5 bullish, 4 bearish.
- FMS’s TA Score: 6 bullish, 3 bearish.
Price Growth
DVA (@Hospital/Nursing Management) experienced а -1.96% price change this week, while FMS (@Hospital/Nursing Management) price change was +2.30% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +2.47%. For the same industry, the average monthly price growth was -1.01%, and the average quarterly price growth was +21.91%.
Reported Earning Dates
DVA is expected to report earnings on Oct 29, 2026.
FMS is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+2.47% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| ACA.X | 0.000299 | 0.000005 | +1.66% |
| Acala Token cryptocurrency | |||
| WBTC.X | 80523.490000 | -352.742200 | -0.44% |
| Wrapped Bitcoin cryptocurrency | |||
| XEC.X | 0.000007 | N/A | -0.60% |
| eCash cryptocurrency | |||
| UMA.X | 0.364472 | -0.004810 | -1.30% |
| UMA cryptocurrency | |||
| GLMR.X | 0.008664 | -0.000237 | -2.66% |
| Moonbeam cryptocurrency | |||
DVA and
Correlation & Price change
A.I.dvisor tells us that DVA and FMS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DVA and FMS's prices will move in lockstep.
| Ticker / NAME | Correlation To DVA | 1D Price Change % | ||
|---|---|---|---|---|
| DVA | 100% | -1.32% | ||
| FMS - DVA | 33% Poorly correlated | +2.02% | ||
| CON - DVA | 31% Poorly correlated | -1.80% | ||
| PNTG - DVA | 25% Poorly correlated | -0.83% | ||
| ASTH - DVA | 25% Poorly correlated | -1.47% | ||
| UHS - DVA | 23% Poorly correlated | -0.66% | ||
More | ||||
FMS and
Correlation & Price change
A.I.dvisor indicates that over the last year, FMS has been loosely correlated with DVA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if FMS jumps, then DVA could also see price increases.